Filed 21d ago· May 13, 2026
41 days to disclose
Byron Donalds
RHouseFlorida-19
↑bought
Eli Lilly
LLY
$1K-$15K
+11.7% vs S&P 500
Trade dateApr 2, 2026
SP Eli Lilly and Company
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–100 of 1,121
Filed 21d ago· May 13, 2026
41 days to discloseByron Donalds
RHouseFlorida-19
↑bought
Eli Lilly
LLY
$1K-$15K
+11.7% vs S&P 500
Trade dateApr 2, 2026
Filed 26d ago· May 8, 2026
Donald J. Trump
RPOTUSFlorida
↑bought
Bristol-Myers Squibb
BMY
$15K-$50K
Trade dateMay 8, 2026
BRISTOL MYERS SQUIBB CO UNSOLICITED
Filed 26d ago· May 8, 2026
Donald J. Trump
RPOTUSFlorida
↑bought
AbbVie
ABBV
$50K-$100K
+5.1% vs S&P 500
Trade dateMay 8, 2026
Filed 26d ago· May 8, 2026
Donald J. Trump
RPOTUSFlorida
↑bought
Vertex Pharmaceuticals
VRTX
$15K+
Trade dateMay 8, 2026
Filed 26d ago· May 8, 2026
9 days to disclose
Gilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Bridgebio Pharma
BBIO
$1K-$15K
−14.8% vs S&P 500
Trade dateApr 29, 2026
Stock
Filed 26d ago· May 8, 2026
21 days to disclose
Maria Elvira Salazar
RHouseFlorida-27
↓sold
Amgen
AMGN
$15K-$50K
Trade dateApr 17, 2026
Filed 26d ago· May 8, 2026
24 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Eli Lilly
LLY
$1K-$15K
+14.6% vs S&P 500
Trade dateApr 14, 2026
Filed 26d ago· May 8, 2026
24 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Zoetis
ZTS
$1K-$15K
Trade dateApr 14, 2026
Filed 1mo ago· May 1, 2026
23 days to disclose
Lizzie Fletcher
DHouseTexas-07
↓sold
Eli Lilly
LLY
$1K-$15K
−0.8% vs S&P 500
Trade dateApr 8, 2026
⚑ Pharmaceutical
Filed 1mo ago· Apr 21, 2026
28 days to discloseMaria Elvira Salazar
RHouseFlorida-27
↑bought
Amgen
AMGN
$15K-$50K
−8.1% vs S&P 500
Trade dateMar 24, 2026
Filed 1mo ago· Apr 14, 2026
26 days to disclose
John Boozman
RSenateArkansas
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+1.3% vs S&P 500
Trade dateMar 19, 2026
Filed 1mo ago· Apr 13, 2026
18 days to disclose
Thomas H. Kean Jr.
RHouseNew Jersey-07
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+1.9% vs S&P 500
Trade dateMar 26, 2026
⚑ Pharmaceutical
Filed 1mo ago· Apr 7, 2026
19 days to disclose
Richard McCormick
RHouseGeorgia-07
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+1.3% vs S&P 500
Trade dateMar 19, 2026
⚑ Pharmaceutical
Filed 1mo ago· Apr 7, 2026
19 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Bridgebio Pharma
BBIO
$1K-$15K
−11.0% vs S&P 500
Trade dateMar 19, 2026
Stock
Filed 1mo ago· Apr 7, 2026
19 days to discloseRichard McCormick
RHouseGeorgia-07
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+1.3% vs S&P 500
Trade dateMar 19, 2026
⚑ Pharmaceutical
Filed 1mo ago· Apr 7, 2026
20 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Bridgebio Pharma
BBIO
$1K-$15K
−10.7% vs S&P 500
Trade dateMar 18, 2026
Stock
Filed 1mo ago· Apr 7, 2026
25 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Eli Lilly
LLY
$1K-$15K
−0.9% vs S&P 500
Trade dateMar 13, 2026
Filed 1mo ago· Apr 7, 2026
25 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Zoetis
ZTS
$1K-$15K
−0.9% vs S&P 500
Trade dateMar 13, 2026
Filed 1mo ago· Apr 7, 2026
29 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Halozyme Therapeutics
HALO
$1K-$15K
+1.0% vs S&P 500
Trade dateMar 9, 2026
Common Stock
Filed 1mo ago· Apr 7, 2026
35 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Pfizer
PFE
$1K-$15K
+5.1% vs S&P 500
Trade dateMar 3, 2026
Pfizer, Inc.
Filed 1mo ago· Apr 7, 2026
35 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Bridgebio Pharma
BBIO
$1K-$15K
+3.3% vs S&P 500
Trade dateMar 3, 2026
Stock
Filed 1mo ago· Apr 7, 2026
35 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Ultragenyx Pharmaceutical
RARE
$1K-$15K
+21.5% vs S&P 500
Trade dateMar 3, 2026
Common Stock
Filed 1mo ago· Apr 6, 2026
27 days to disclose
Lloyd Doggett
DHouseTexas-37
↑bought
Johnson & Johnson
JNJ
$1K-$15K
−2.1% vs S&P 500
Trade dateMar 10, 2026
⚑ Pharmaceutical
Filed 2mo ago· Apr 3, 2026
10 days to disclose
Kevin Hern
RHouseOklahoma-01
↓sold
Exact Sciences
EXAS
$1K-$15K
Trade dateMar 24, 2026
Common Stock
⚑ Pharmaceutical
Filed 2mo ago· Mar 25, 2026
50 days to disclose · 5 past 45-day window
Susan M. Collins
RSenateMaine
↑bought
Pfizer
PFE
$15K-$50K
Trade dateFeb 3, 2026
Bond⚑ Pharmaceutical
Filed 2mo ago· Mar 24, 2026
39 days to disclose
Angus S., Jr. King
ISenateMaine
↓sold
Eli Lilly
LLY
$1K-$15K
−5.8% vs S&P 500
Trade dateFeb 13, 2026
Filed 2mo ago· Mar 16, 2026
40 days to disclose
Josh Gottheimer
DHouseNew Jersey-05
↑bought
Merck
MRK
$1K-$15K
+0.8% vs S&P 500
Trade dateFeb 4, 2026
Stock
Filed 2mo ago· Mar 12, 2026
28 days to disclose
Julia Letlow
RHouseLouisiana-05
↑bought
Regeneron Pharmaceuticals
REGN
$1K-$15K
−3.2% vs S&P 500
Trade dateFeb 12, 2026
Common Stock
Filed 2mo ago· Mar 9, 2026
19 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Ultragenyx Pharmaceutical
RARE
$1K-$15K
+31.2% vs S&P 500
Trade dateFeb 18, 2026
Common Stock
Filed 2mo ago· Mar 9, 2026
19 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Pfizer
PFE
$1K-$15K
−5.8% vs S&P 500
Trade dateFeb 18, 2026
Pfizer, Inc.
Filed 2mo ago· Mar 9, 2026
27 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Zoetis
ZTS
$1K-$15K
−36.0% vs S&P 500
Trade dateFeb 10, 2026
Filed 2mo ago· Mar 6, 2026
8 days to disclose
David J. Taylor
RHouseOhio-02
↓sold
Amgen
AMGN
$1K-$15K
−5.7% vs S&P 500
Trade dateFeb 26, 2026
Filed 2mo ago· Mar 6, 2026
8 days to discloseDavid J. Taylor
RHouseOhio-02
↑bought
Eli Lilly
LLY
$1K-$15K
+8.9% vs S&P 500
Trade dateFeb 26, 2026
Filed 3mo ago· Feb 26, 2026
30 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Gilead Sciences
GILD
$1K-$15K
+0.3% vs S&P 500
Trade dateJan 27, 2026
Filed 3mo ago· Feb 20, 2026
11 days to discloseDavid J. Taylor
RHouseOhio-02
↓sold
Eli Lilly
LLY
$1K-$15K
−5.0% vs S&P 500
Trade dateFeb 9, 2026
Filed 3mo ago· Feb 19, 2026
27 days to discloseThomas H. Kean Jr.
RHouseNew Jersey-07
↓sold
Johnson & Johnson
JNJ
$15K-$50K
−5.7% vs S&P 500
Trade dateJan 23, 2026
⚑ Pharmaceutical
Filed 3mo ago· Feb 13, 2026
14 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Biogen
BIIB
$1K-$15K
+10.0% vs S&P 500
Trade dateJan 30, 2026
Filed 4mo ago· Feb 2, 2026
4 days to discloseDavid J. Taylor
RHouseOhio-02
↓sold
Vertex Pharmaceuticals
VRTX
$1K-$15K
−3.5% vs S&P 500
Trade dateJan 29, 2026
-
Filed 4mo ago· Feb 2, 2026
4 days to discloseDavid J. Taylor
RHouseOhio-02
↓sold
Amgen
AMGN
$1K-$15K
−3.5% vs S&P 500
Trade dateJan 29, 2026
Filed 4mo ago· Feb 2, 2026
17 days to discloseDavid J. Taylor
RHouseOhio-02
↑bought
Amgen
AMGN
$1K-$15K
+3.8% vs S&P 500
Trade dateJan 16, 2026
Filed 4mo ago· Feb 2, 2026
17 days to discloseDavid J. Taylor
RHouseOhio-02
↓sold
Eli Lilly
LLY
$1K-$15K
−4.6% vs S&P 500
Trade dateJan 16, 2026
Filed 4mo ago· Jan 26, 2026
28 days to discloseAngus S., Jr. King
ISenateMaine
↑bought
Eli Lilly
LLY
$1K-$15K
+3.8% vs S&P 500
Trade dateDec 29, 2025
Filed 4mo ago· Jan 23, 2026
23 days to disclose
J. French Hill
RHouseArkansas-02
↓sold
Pfizer
PFE
$15K-$30K
−4.1% vs S&P 500
Trade dateDec 31, 2025
Pfizer, Inc.
Filed 4mo ago· Jan 16, 2026
18 days to disclose
Markwayne Mullin
RSenateOklahoma
↑bought
Eli Lilly
LLY
$15K-$50K
+2.5% vs S&P 500
Trade dateDec 29, 2025
Filed 4mo ago· Jan 15, 2026
28 days to disclose
Julie Johnson
DHouseTexas-32
↓sold
Merck
MRK
$1K-$15K
−3.5% vs S&P 500
Trade dateDec 18, 2025
Stock
Filed 4mo ago· Jan 15, 2026
28 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Johnson & Johnson
JNJ
$1K-$15K
−3.5% vs S&P 500
Trade dateDec 18, 2025
Filed 4mo ago· Jan 15, 2026
28 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Eli Lilly
LLY
$1K-$15K
−3.5% vs S&P 500
Trade dateDec 18, 2025
Filed 4mo ago· Jan 15, 2026
28 days to discloseJulie Johnson
DHouseTexas-32
↓sold
AbbVie
ABBV
$1K-$15K
−3.5% vs S&P 500
Trade dateDec 18, 2025
Filed 4mo ago· Jan 15, 2026
28 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
−3.5% vs S&P 500
Trade dateDec 18, 2025
Common Stock
Filed 4mo ago· Jan 13, 2026
36 days to discloseJulia Letlow
RHouseLouisiana-05
↑bought
AstraZeneca
AZN
$1K-$15K
+3.2% vs S&P 500
Trade dateDec 8, 2025
Depositary Shares
Filed 4mo ago· Jan 13, 2026
36 days to discloseJulia Letlow
RHouseLouisiana-05
↓sold
AbbVie
ABBV
$1K-$15K
−1.9% vs S&P 500
Trade dateDec 8, 2025
Filed 4mo ago· Jan 13, 2026
260 days to disclose · 215 past 45-day windowJulia Letlow
RHouseLouisiana-05
↑bought
AbbVie
ABBV
$1K-$15K
+5.0% vs S&P 500
Trade dateApr 28, 2025
Filed 4mo ago· Jan 13, 2026
260 days to disclose · 215 past 45-day windowJulia Letlow
RHouseLouisiana-05
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+7.2% vs S&P 500
Trade dateApr 28, 2025
Common Stock
Filed 4mo ago· Jan 13, 2026
354 days to disclose · 309 past 45-day windowJulia Letlow
RHouseLouisiana-05
↓sold
AbbVie
ABBV
$1K-$15K
+2.9% vs S&P 500
Trade dateJan 24, 2025
Filed 4mo ago· Jan 13, 2026
420 days to disclose · 375 past 45-day windowJulia Letlow
RHouseLouisiana-05
↓sold
Amgen
AMGN
$1K-$15K
+5.2% vs S&P 500
Trade dateNov 19, 2024
Filed 4mo ago· Jan 13, 2026
447 days to disclose · 402 past 45-day windowJulia Letlow
RHouseLouisiana-05
↑bought
Vertex Pharmaceuticals
VRTX
$1K-$15K
−8.0% vs S&P 500
Trade dateOct 23, 2024
-
Filed 4mo ago· Jan 13, 2026
447 days to disclose · 402 past 45-day windowJulia Letlow
RHouseLouisiana-05
↑bought
Amgen
AMGN
$1K-$15K
+5.7% vs S&P 500
Trade dateOct 23, 2024
Filed 4mo ago· Jan 13, 2026
447 days to disclose · 402 past 45-day windowJulia Letlow
RHouseLouisiana-05
↑bought
AbbVie
ABBV
$1K-$15K
+16.0% vs S&P 500
Trade dateOct 23, 2024
Filed 4mo ago· Jan 13, 2026
447 days to disclose · 402 past 45-day windowJulia Letlow
RHouseLouisiana-05
↑bought
Bristol-Myers Squibb
BMY
$1K-$15K
+3.9% vs S&P 500
Trade dateOct 23, 2024
Common Stock
Filed 4mo ago· Jan 13, 2026
447 days to disclose · 402 past 45-day windowJulia Letlow
RHouseLouisiana-05
↑bought
Pfizer
PFE
$1K-$15K
−6.8% vs S&P 500
Trade dateOct 23, 2024
Pfizer, Inc.
Filed 4mo ago· Jan 12, 2026
24 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Bristol-Myers Squibb
BMY
$1K-$15K
+5.1% vs S&P 500
Trade dateDec 19, 2025
Common Stock
Filed 4mo ago· Jan 12, 2026
24 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Merck
MRK
$1K-$15K
+16.5% vs S&P 500
Trade dateDec 19, 2025
Stock
Filed 4mo ago· Jan 12, 2026
24 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Zoetis
ZTS
$1K-$15K
−33.4% vs S&P 500
Trade dateDec 19, 2025
Filed 4mo ago· Jan 12, 2026
25 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
AstraZeneca
AZN
$1K-$15K
+5.6% vs S&P 500
Trade dateDec 18, 2025
Depositary Shares
Filed 4mo ago· Jan 12, 2026
32 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Pfizer
PFE
$1K-$15K
−3.3% vs S&P 500
Trade dateDec 11, 2025
Pfizer, Inc.
Filed 5mo ago· Jan 2, 2026
24 days to discloseLloyd Doggett
DHouseTexas-37
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+16.6% vs S&P 500
Trade dateDec 9, 2025
⚑ Pharmaceutical
Filed 5mo ago· Dec 19, 2025
9 days to discloseDavid J. Taylor
RHouseOhio-02
↓sold
Eli Lilly
LLY
$1K-$15K
−2.4% vs S&P 500
Trade dateDec 10, 2025
Filed 5mo ago· Dec 19, 2025
29 days to discloseThomas H. Kean Jr.
RHouseNew Jersey-07
↓sold
Johnson & Johnson
JNJ
$15K-$50K
−1.9% vs S&P 500
Trade dateNov 20, 2025
⚑ Pharmaceutical
Filed 5mo ago· Dec 15, 2025
26 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
AstraZeneca
AZN
$1K-$15K
+6.4% vs S&P 500
Trade dateNov 19, 2025
Depositary Shares
Filed 5mo ago· Dec 15, 2025
27 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Regeneron Pharmaceuticals
REGN
$1K-$15K
+2.1% vs S&P 500
Trade dateNov 18, 2025
Common Stock
Filed 5mo ago· Dec 15, 2025
27 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Eli Lilly
LLY
$1K-$15K
+5.1% vs S&P 500
Trade dateNov 18, 2025
Filed 5mo ago· Dec 15, 2025
27 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Zoetis
ZTS
$1K-$15K
−32.7% vs S&P 500
Trade dateNov 18, 2025
Filed 5mo ago· Dec 15, 2025
27 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Merck
MRK
$1K-$15K
+20.4% vs S&P 500
Trade dateNov 18, 2025
Stock
Filed 5mo ago· Dec 15, 2025
33 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Bristol-Myers Squibb
BMY
$1K-$15K
+14.2% vs S&P 500
Trade dateNov 12, 2025
Common Stock
Filed 5mo ago· Dec 11, 2025
28 days to discloseJulie Johnson
DHouseTexas-32
↓sold
AbbVie
ABBV
$1K-$15K
−2.8% vs S&P 500
Trade dateNov 13, 2025
Filed 5mo ago· Dec 11, 2025
28 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Johnson & Johnson
JNJ
$1K-$15K
−2.8% vs S&P 500
Trade dateNov 13, 2025
Filed 5mo ago· Dec 11, 2025
28 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
−2.8% vs S&P 500
Trade dateNov 13, 2025
Common Stock
Filed 5mo ago· Dec 11, 2025
28 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Merck
MRK
$1K-$15K
−2.8% vs S&P 500
Trade dateNov 13, 2025
Stock
Filed 5mo ago· Dec 11, 2025
28 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Eli Lilly
LLY
$1K-$15K
−2.8% vs S&P 500
Trade dateNov 13, 2025
Filed 5mo ago· Dec 9, 2025
34 days to discloseRichard McCormick
RHouseGeorgia-07
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+22.4% vs S&P 500
Trade dateNov 5, 2025
⚑ Pharmaceutical
Filed 5mo ago· Dec 8, 2025
17 days to discloseJohn Boozman
RSenateArkansas
↓sold
Eli Lilly
LLY
$1K-$15K
−3.9% vs S&P 500
Trade dateNov 21, 2025
Filed 6mo ago· Dec 5, 2025
2 days to discloseDavid J. Taylor
RHouseOhio-02
↓sold
Amgen
AMGN
$1K-$15K
−4.2% vs S&P 500
Trade dateDec 3, 2025
Filed 6mo ago· Dec 5, 2025
2 days to discloseDavid J. Taylor
RHouseOhio-02
↓sold
Amgen
AMGN
$1K-$15K
−4.2% vs S&P 500
Trade dateDec 3, 2025
Filed 6mo ago· Dec 5, 2025
25 days to discloseMarkwayne Mullin
RSenateOklahoma
↓sold
Zoetis
ZTS
$15K-$50K
+0.8% vs S&P 500
Trade dateNov 10, 2025
Filed 6mo ago· Nov 22, 2025
43 days to disclose
Jared Moskowitz
DHouseFlorida-23
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+4.5% vs S&P 500
Trade dateOct 10, 2025
Filed 6mo ago· Nov 22, 2025
43 days to discloseJared Moskowitz
DHouseFlorida-23
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+4.5% vs S&P 500
Trade dateOct 10, 2025
Filed 6mo ago· Nov 21, 2025
21 days to disclose
Lisa C. McClain
RHouseMichigan-09
↓sold
AstraZeneca
AZN
$1K-$15K
+3.0% vs S&P 500
Trade dateOct 31, 2025
Depositary Shares
⚑ Pharmaceutical
Filed 6mo ago· Nov 21, 2025
21 days to discloseLisa C. McClain
RHouseMichigan-09
↓sold
United Therapeutics
UTHR
$1K-$15K
+3.0% vs S&P 500
Trade dateOct 31, 2025
Common Stock
⚑ Pharmaceutical
Filed 6mo ago· Nov 21, 2025
21 days to discloseLisa C. McClain
RHouseMichigan-09
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+3.0% vs S&P 500
Trade dateOct 31, 2025
⚑ Pharmaceutical
Filed 6mo ago· Nov 21, 2025
21 days to discloseLisa C. McClain
RHouseMichigan-09
↓sold
Novartis Ag
NVS
$1K-$15K
+3.0% vs S&P 500
Trade dateOct 31, 2025
⚑ Pharmaceutical
Filed 6mo ago· Nov 21, 2025
21 days to discloseLisa C. McClain
RHouseMichigan-09
↓sold
Novo Nordisk
NVO
$1K-$15K
+3.0% vs S&P 500
Trade dateOct 31, 2025
⚑ Pharmaceutical
Filed 6mo ago· Nov 21, 2025
21 days to discloseLisa C. McClain
RHouseMichigan-09
↓sold
Repligen
RGEN
$1K-$15K
+3.0% vs S&P 500
Trade dateOct 31, 2025
Stock
⚑ Pharmaceutical
Filed 6mo ago· Nov 21, 2025
21 days to discloseLisa C. McClain
RHouseMichigan-09
↓sold
GSK PLC
GSK
$1K-$15K
+3.0% vs S&P 500
Trade dateOct 31, 2025
⚑ Pharmaceutical
Filed 6mo ago· Nov 21, 2025
21 days to discloseLisa C. McClain
RHouseMichigan-09
↓sold
AbbVie
ABBV
$1K-$15K
+3.0% vs S&P 500
Trade dateOct 31, 2025
⚑ Pharmaceutical
Filed 6mo ago· Nov 21, 2025
22 days to discloseLisa C. McClain
RHouseMichigan-09
↓sold
United Therapeutics
UTHR
$1K-$15K
+2.9% vs S&P 500
Trade dateOct 30, 2025
Common Stock
⚑ Pharmaceutical
Filed 6mo ago· Nov 21, 2025
22 days to discloseLisa C. McClain
RHouseMichigan-09
↓sold
GSK PLC
GSK
$1K-$15K
+2.9% vs S&P 500
Trade dateOct 30, 2025
⚑ Pharmaceutical
Filed 6mo ago· Nov 21, 2025
22 days to discloseLisa C. McClain
RHouseMichigan-09
↑bought
Novartis Ag
NVS
$1K-$15K
+18.1% vs S&P 500
Trade dateOct 30, 2025
⚑ Pharmaceutical
Filed 6mo ago· Nov 21, 2025
22 days to discloseLisa C. McClain
RHouseMichigan-09
↓sold
Novartis Ag
NVS
$1K-$15K
+2.9% vs S&P 500
Trade dateOct 30, 2025
⚑ Pharmaceutical
Filed 6mo ago· Nov 21, 2025
22 days to discloseLisa C. McClain
RHouseMichigan-09
↓sold
Novo Nordisk
NVO
$1K-$15K
+2.9% vs S&P 500
Trade dateOct 30, 2025
⚑ Pharmaceutical
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
May 13, 2026 21d ago | Byron Donalds RHouseFlorida-19 | ↑bought | Eli Lilly LLY SP Eli Lilly and Company | Apr 2, 2026 41 days to disclose | Good buy·+$1K+12.8% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 13, 2026 21d ago | Byron Donalds RHouseFlorida-19 | ↑bought | Eli Lilly LLY | Apr 2, 2026 41 days to disclose | Good buy·+$1K+12.8% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 8, 2026 26d ago | Donald J. Trump RPOTUSFlorida | ↑bought | Bristol-Myers Squibb BMY BRISTOL MYERS SQUIBB CO UNSOLICITED | May 8, 2026 | price pending | $15K-$50K midpoint $32.5K |
May 8, 2026 26d ago | Donald J. Trump RPOTUSFlorida | ↑bought | AbbVie ABBV | May 8, 2026 | Good buy·+$4.8K+6.3% +5.1% vs S&P 500 | $50K-$100K midpoint $75K |
May 8, 2026 26d ago | Donald J. Trump RPOTUSFlorida | ↑bought | Vertex Pharmaceuticals VRTX | May 8, 2026 | price pending | $15K+ midpoint $15K |
May 8, 2026 26d ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Bridgebio Pharma BBIO Stock | Apr 29, 2026 9 days to disclose | Bad buy·−$868-10.9% −14.8% vs S&P 500 | $1K-$15K midpoint $8K |
May 8, 2026 26d ago | Maria Elvira Salazar RHouseFlorida-27 | ↓sold | Amgen AMGN | Apr 17, 2026 21 days to disclose | Flat·+0.0% | $15K-$50K midpoint $32.5K |
May 8, 2026 26d ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Eli Lilly LLY | Apr 14, 2026 24 days to disclose | Good buy·+$1.2K+14.4% +14.6% vs S&P 500 | $1K-$15K midpoint $8K |
May 8, 2026 26d ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Zoetis ZTS | Apr 14, 2026 24 days to disclose | Flat·+0.0% | $1K-$15K midpoint $8K |
May 1, 2026 1mo ago | Lizzie Fletcher DHouseTexas-07 | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Energy and Commerce | Apr 8, 2026 23 days to disclose | Flat·+0.0% −0.8% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 21, 2026 1mo ago | Maria Elvira Salazar RHouseFlorida-27 | ↑bought | Amgen AMGN | Mar 24, 2026 28 days to disclose | Bad buy·−$1.8K-5.6% −8.1% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 14, 2026 1mo ago | John Boozman RSenateArkansas | ↓sold | Johnson & Johnson JNJ | Mar 19, 2026 26 days to disclose | Flat·+0.0% +1.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 13, 2026 1mo ago | Thomas H. Kean Jr. RHouseNew Jersey-07 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Energy and Commerce | Mar 26, 2026 18 days to disclose | Flat·+0.0% +1.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2026 1mo ago | Richard McCormick RHouseGeorgia-07 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Investigations and Oversight | Mar 19, 2026 19 days to disclose | Flat·+0.0% +1.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2026 1mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Bridgebio Pharma BBIO Stock | Mar 19, 2026 19 days to disclose | Bad buy·−$780-9.7% −11.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2026 1mo ago | Richard McCormick RHouseGeorgia-07 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Investigations and Oversight | Mar 19, 2026 19 days to disclose | Flat·+0.0% +1.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2026 1mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Bridgebio Pharma BBIO Stock | Mar 18, 2026 20 days to disclose | Bad buy·−$785-9.8% −10.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2026 1mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Eli Lilly LLY | Mar 13, 2026 25 days to disclose | Flat·+0.0% −0.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2026 1mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Zoetis ZTS | Mar 13, 2026 25 days to disclose | Flat·+0.0% −0.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2026 1mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Halozyme Therapeutics HALO Common Stock | Mar 9, 2026 29 days to disclose | Bad buy·−$222-2.8% +1.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2026 1mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Pfizer PFE Pfizer, Inc. | Mar 3, 2026 35 days to disclose | Flat·-0.2% +5.1% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2026 1mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Bridgebio Pharma BBIO Stock | Mar 3, 2026 35 days to disclose | Bad buy·−$160-2.0% +3.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2026 1mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Ultragenyx Pharmaceutical RARE Common Stock | Mar 3, 2026 35 days to disclose | Good buy·+$1.3K+16.2% +21.5% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 6, 2026 1mo ago | Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Mar 10, 2026 27 days to disclose | Bad buy·−$407-5.1% −2.1% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 3, 2026 2mo ago | Kevin Hern RHouseOklahoma-01 | ↓sold | Exact Sciences EXAS Common Stock ⚑ Pharmaceutical · Ways and Means | Mar 24, 2026 10 days to disclose | price pending | $1K-$15K midpoint $8K |
Mar 25, 2026 2mo ago | Susan M. Collins RSenateMaine | ↑bought | Pfizer PFE Bond⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Feb 3, 2026 50 days to disclose · 5 past 45-day window | price pending | $15K-$50K midpoint $32.5K |
Mar 24, 2026 2mo ago | Angus S., Jr. King ISenateMaine | ↓sold | Eli Lilly LLY | Feb 13, 2026 39 days to disclose | Flat·+0.0% −5.8% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 16, 2026 2mo ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Merck MRK Stock | Feb 4, 2026 40 days to disclose | Bad buy·−$323-4.0% +0.8% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 12, 2026 2mo ago | Julia Letlow RHouseLouisiana-05 | ↑bought | Regeneron Pharmaceuticals REGN Common Stock | Feb 12, 2026 28 days to disclose | Bad buy·−$639-8.0% −3.2% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 9, 2026 2mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Ultragenyx Pharmaceutical RARE Common Stock | Feb 18, 2026 19 days to disclose | Good buy·+$2K+25.4% +31.2% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 9, 2026 2mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Pfizer PFE Pfizer, Inc. | Feb 18, 2026 19 days to disclose | Flat·+0.0% −5.8% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 9, 2026 2mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Zoetis ZTS | Feb 10, 2026 27 days to disclose | Bad buy·−$3.2K-40.4% −36.0% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 6, 2026 2mo ago | David J. Taylor RHouseOhio-02 | ↓sold | Amgen AMGN | Feb 26, 2026 8 days to disclose | Flat·+0.0% −5.7% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 6, 2026 2mo ago | David J. Taylor RHouseOhio-02 | ↑bought | Eli Lilly LLY | Feb 26, 2026 8 days to disclose | Good buy·+$262+3.3% +8.9% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 26, 2026 3mo ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Gilead Sciences GILD | Jan 27, 2026 30 days to disclose | Bad buy·−$333-4.2% +0.3% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 20, 2026 3mo ago | David J. Taylor RHouseOhio-02 | ↓sold | Eli Lilly LLY | Feb 9, 2026 11 days to disclose | Flat·+0.0% −5.0% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 19, 2026 3mo ago | Thomas H. Kean Jr. RHouseNew Jersey-07 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Energy and Commerce | Jan 23, 2026 27 days to disclose | Flat·+0.0% −5.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
Feb 13, 2026 3mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Biogen BIIB | Jan 30, 2026 14 days to disclose | Good buy·+$480+6.0% +10.0% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 2, 2026 4mo ago | David J. Taylor RHouseOhio-02 | ↓sold | Vertex Pharmaceuticals VRTX - | Jan 29, 2026 4 days to disclose | Flat·+0.0% −3.5% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 2, 2026 4mo ago | David J. Taylor RHouseOhio-02 | ↓sold | Amgen AMGN | Jan 29, 2026 4 days to disclose | Flat·+0.0% −3.5% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 2, 2026 4mo ago | David J. Taylor RHouseOhio-02 | ↑bought | Amgen AMGN | Jan 16, 2026 17 days to disclose | Bad buy·−$69-0.9% +3.8% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 2, 2026 4mo ago | David J. Taylor RHouseOhio-02 | ↓sold | Eli Lilly LLY | Jan 16, 2026 17 days to disclose | Flat·+0.0% −4.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 26, 2026 4mo ago | Angus S., Jr. King ISenateMaine | ↑bought | Eli Lilly LLY | Dec 29, 2025 28 days to disclose | Bad buy·−$67-0.8% +3.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 23, 2026 4mo ago | J. French Hill RHouseArkansas-02 | ↓sold | Pfizer PFE Pfizer, Inc. | Dec 31, 2025 23 days to disclose | Flat·+0.0% −4.1% vs S&P 500 | $15K-$30K midpoint $22.5K |
Jan 16, 2026 4mo ago | Markwayne Mullin RSenateOklahoma | ↑bought | Eli Lilly LLY | Dec 29, 2025 18 days to disclose | Bad buy·−$701-2.2% +2.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jan 15, 2026 4mo ago | Julie Johnson DHouseTexas-32 | ↓sold | Merck MRK Stock | Dec 18, 2025 28 days to disclose | Flat·+0.0% −3.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 15, 2026 4mo ago | Julie Johnson DHouseTexas-32 | ↓sold | Johnson & Johnson JNJ | Dec 18, 2025 28 days to disclose | Flat·+0.0% −3.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 15, 2026 4mo ago | Julie Johnson DHouseTexas-32 | ↓sold | Eli Lilly LLY | Dec 18, 2025 28 days to disclose | Flat·+0.0% −3.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 15, 2026 4mo ago | Julie Johnson DHouseTexas-32 | ↓sold | AbbVie ABBV | Dec 18, 2025 28 days to disclose | Flat·+0.0% −3.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 15, 2026 4mo ago | Julie Johnson DHouseTexas-32 | ↓sold | Bristol-Myers Squibb BMY Common Stock | Dec 18, 2025 28 days to disclose | Flat·+0.0% −3.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 13, 2026 4mo ago | Julia Letlow RHouseLouisiana-05 | ↑bought | AstraZeneca AZN Depositary Shares | Dec 8, 2025 36 days to disclose | Good buy·+$103+1.3% +3.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 13, 2026 4mo ago | Julia Letlow RHouseLouisiana-05 | ↓sold | AbbVie ABBV | Dec 8, 2025 36 days to disclose | Flat·+0.0% −1.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 13, 2026 4mo ago | Julia Letlow RHouseLouisiana-05 | ↑bought | AbbVie ABBV | Apr 28, 2025 260 days to disclose · 215 past 45-day window | Good buy·+$970+12.1% +5.0% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 13, 2026 4mo ago | Julia Letlow RHouseLouisiana-05 | ↓sold | Bristol-Myers Squibb BMY Common Stock | Apr 28, 2025 260 days to disclose · 215 past 45-day window | Flat·+0.0% +7.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 13, 2026 4mo ago | Julia Letlow RHouseLouisiana-05 | ↓sold | AbbVie ABBV | Jan 24, 2025 354 days to disclose · 309 past 45-day window | Flat·+0.0% +2.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 13, 2026 4mo ago | Julia Letlow RHouseLouisiana-05 | ↓sold | Amgen AMGN | Nov 19, 2024 420 days to disclose · 375 past 45-day window | Flat·+0.0% +5.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 13, 2026 4mo ago | Julia Letlow RHouseLouisiana-05 | ↑bought | Vertex Pharmaceuticals VRTX - | Oct 23, 2024 447 days to disclose · 402 past 45-day window | Bad buy·−$738-9.2% −8.0% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 13, 2026 4mo ago | Julia Letlow RHouseLouisiana-05 | ↑bought | Amgen AMGN | Oct 23, 2024 447 days to disclose · 402 past 45-day window | Good buy·+$359+4.5% +5.7% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 13, 2026 4mo ago | Julia Letlow RHouseLouisiana-05 | ↑bought | AbbVie ABBV | Oct 23, 2024 447 days to disclose · 402 past 45-day window | Good buy·+$1.2K+14.8% +16.0% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 13, 2026 4mo ago | Julia Letlow RHouseLouisiana-05 | ↑bought | Bristol-Myers Squibb BMY Common Stock | Oct 23, 2024 447 days to disclose · 402 past 45-day window | Good buy·+$211+2.6% +3.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 13, 2026 4mo ago | Julia Letlow RHouseLouisiana-05 | ↑bought | Pfizer PFE Pfizer, Inc. | Oct 23, 2024 447 days to disclose · 402 past 45-day window | Bad buy·−$646-8.1% −6.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 12, 2026 4mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Bristol-Myers Squibb BMY Common Stock | Dec 19, 2025 24 days to disclose | Good buy·+$73+0.9% +5.1% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 12, 2026 4mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Merck MRK Stock | Dec 19, 2025 24 days to disclose | Good buy·+$987+12.3% +16.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 12, 2026 4mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Zoetis ZTS | Dec 19, 2025 24 days to disclose | Bad buy·−$3K-37.6% −33.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 12, 2026 4mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | AstraZeneca AZN Depositary Shares | Dec 18, 2025 25 days to disclose | Good buy·+$163+2.0% +5.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 12, 2026 4mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Pfizer PFE Pfizer, Inc. | Dec 11, 2025 32 days to disclose | Flat·+0.0% −3.3% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 2, 2026 5mo ago | Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Dec 9, 2025 24 days to disclose | Good buy·+$1.3K+15.7% +16.6% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 19, 2025 5mo ago | David J. Taylor RHouseOhio-02 | ↓sold | Eli Lilly LLY | Dec 10, 2025 9 days to disclose | Flat·+0.0% −2.4% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 19, 2025 5mo ago | Thomas H. Kean Jr. RHouseNew Jersey-07 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Energy and Commerce | Nov 20, 2025 29 days to disclose | Flat·+0.0% −1.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
Dec 15, 2025 5mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | AstraZeneca AZN Depositary Shares | Nov 19, 2025 26 days to disclose | Good buy·+$312+3.9% +6.4% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 15, 2025 5mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Regeneron Pharmaceuticals REGN Common Stock | Nov 18, 2025 27 days to disclose | Bad buy·−$47-0.6% +2.1% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 15, 2025 5mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Eli Lilly LLY | Nov 18, 2025 27 days to disclose | Good buy·+$197+2.5% +5.1% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 15, 2025 5mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Zoetis ZTS | Nov 18, 2025 27 days to disclose | Bad buy·−$2.8K-35.4% −32.7% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 15, 2025 5mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Merck MRK Stock | Nov 18, 2025 27 days to disclose | Good buy·+$1.4K+17.8% +20.4% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 15, 2025 5mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Bristol-Myers Squibb BMY Common Stock | Nov 12, 2025 33 days to disclose | Good buy·+$914+11.4% +14.2% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 11, 2025 5mo ago | Julie Johnson DHouseTexas-32 | ↓sold | AbbVie ABBV | Nov 13, 2025 28 days to disclose | Flat·+0.0% −2.8% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 11, 2025 5mo ago | Julie Johnson DHouseTexas-32 | ↓sold | Johnson & Johnson JNJ | Nov 13, 2025 28 days to disclose | Flat·+0.0% −2.8% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 11, 2025 5mo ago | Julie Johnson DHouseTexas-32 | ↓sold | Bristol-Myers Squibb BMY Common Stock | Nov 13, 2025 28 days to disclose | Flat·+0.0% −2.8% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 11, 2025 5mo ago | Julie Johnson DHouseTexas-32 | ↓sold | Merck MRK Stock | Nov 13, 2025 28 days to disclose | Flat·+0.0% −2.8% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 11, 2025 5mo ago | Julie Johnson DHouseTexas-32 | ↓sold | Eli Lilly LLY | Nov 13, 2025 28 days to disclose | Flat·+0.0% −2.8% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 9, 2025 5mo ago | Richard McCormick RHouseGeorgia-07 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Investigations and Oversight | Nov 5, 2025 34 days to disclose | Good buy·+$1.9K+24.4% +22.4% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 8, 2025 5mo ago | John Boozman RSenateArkansas | ↓sold | Eli Lilly LLY | Nov 21, 2025 17 days to disclose | Flat·+0.0% −3.9% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 5, 2025 6mo ago | David J. Taylor RHouseOhio-02 | ↓sold | Amgen AMGN | Dec 3, 2025 2 days to disclose | Flat·+0.0% −4.2% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 5, 2025 6mo ago | David J. Taylor RHouseOhio-02 | ↓sold | Amgen AMGN | Dec 3, 2025 2 days to disclose | Flat·+0.0% −4.2% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 5, 2025 6mo ago | Markwayne Mullin RSenateOklahoma | ↓sold | Zoetis ZTS | Nov 10, 2025 25 days to disclose | Flat·+0.0% +0.8% vs S&P 500 | $15K-$50K midpoint $32.5K |
Nov 22, 2025 6mo ago | Jared Moskowitz DHouseFlorida-23 | ↓sold | Johnson & Johnson JNJ | Oct 10, 2025 43 days to disclose | Flat·+0.0% +4.5% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 22, 2025 6mo ago | Jared Moskowitz DHouseFlorida-23 | ↓sold | Johnson & Johnson JNJ | Oct 10, 2025 43 days to disclose | Flat·+0.0% +4.5% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | AstraZeneca AZN Depositary Shares ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 31, 2025 21 days to disclose | Flat·+0.0% +3.0% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | United Therapeutics UTHR Common Stock ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 31, 2025 21 days to disclose | Flat·+0.0% +3.0% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 31, 2025 21 days to disclose | Flat·+0.0% +3.0% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | Novartis Ag NVS ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 31, 2025 21 days to disclose | Flat·+0.0% +3.0% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | Novo Nordisk NVO ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 31, 2025 21 days to disclose | Flat·+0.0% +3.0% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | Repligen RGEN Stock ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 31, 2025 21 days to disclose | Flat·+0.0% +3.0% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | GSK PLC GSK ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 31, 2025 21 days to disclose | Flat·+0.0% +3.0% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | AbbVie ABBV ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 31, 2025 21 days to disclose | Flat·+0.0% +3.0% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | United Therapeutics UTHR Common Stock ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 30, 2025 22 days to disclose | Flat·+0.0% +2.9% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | GSK PLC GSK ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 30, 2025 22 days to disclose | Flat·+0.0% +2.9% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | Lisa C. McClain RHouseMichigan-09 | ↑bought | Novartis Ag NVS ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 30, 2025 22 days to disclose | Good buy·+$1.7K+21.0% +18.1% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | Novartis Ag NVS ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 30, 2025 22 days to disclose | Flat·+0.0% +2.9% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | Novo Nordisk NVO ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 30, 2025 22 days to disclose | Flat·+0.0% +2.9% vs S&P 500 | $1K-$15K midpoint $8K |